GRNA - GreenLight Biosciences GAAP EPS of -$0.42 revenue of $1.77M
- GreenLight Biosciences press release ( NASDAQ: GRNA ): Q2 GAAP EPS of -$0.42.
- Revenue of $1.77M (+261.2% Y/Y).
- Cash, cash equivalents, and marketable securities were $44.1 million as of June 30, 2022, compared to $31.4 million as of December 31, 2021.
For further details see:
GreenLight Biosciences GAAP EPS of -$0.42, revenue of $1.77M